133 related articles for article (PubMed ID: 793999)
21. [Therapeutic trials with the new antihypertensive agent Tadip].
Stein G
Med Klin; 1968 Sep; 63(37):1466-8. PubMed ID: 5730203
[No Abstract] [Full Text] [Related]
22. Long term comparative study of guanfacine and alpha-methyldopa in essential hypertension.
Rengo F; Ricciardelli B; Volpe M; Trimarco B; Saccà L; Condorelli M
Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):281-91. PubMed ID: 6996627
[TBL] [Abstract][Full Text] [Related]
23. The antihypertensive effect of guanfacine compared with methyldopa.
van der Merwe CJ; Kruger SA
S Afr Med J; 1980 Mar; 57(11):400-4. PubMed ID: 6105713
[TBL] [Abstract][Full Text] [Related]
24. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G
Arzneimittelforschung; 1980; 30(6):1005-7. PubMed ID: 6998487
[TBL] [Abstract][Full Text] [Related]
25. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
Jerie P; Lasance A
Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):279-87. PubMed ID: 7030975
[TBL] [Abstract][Full Text] [Related]
26. [Guanfacine in the treatment of arterial hypertension. Apropos of 471 cases in a hospital milieu].
Carette B
Ann Cardiol Angeiol (Paris); 1984; 33(2):123-6. PubMed ID: 6143529
[No Abstract] [Full Text] [Related]
27. Antihypertensive effect of BS 100-141, a new central acting antihypertensive agent.
Lochaya S; Thongmitr V; Suvachittanont O
Am Heart J; 1980 Jan; 99(1):58-63. PubMed ID: 7350752
[TBL] [Abstract][Full Text] [Related]
28. [Guanfacinum (BS 100-14) in long-term therapy of severe hypertension].
Röckel A; Sabel B; Heidland A
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():314-8. PubMed ID: 347805
[No Abstract] [Full Text] [Related]
29. Long-term clinical experience with guanfacine.
Fetkovská N; Brimichová G; Sebeková K; Dzúrik R
Cor Vasa; 1987; 29(4 Suppl 1):23-9. PubMed ID: 3315447
[TBL] [Abstract][Full Text] [Related]
30. [Improvement of the functional capacity of hypertensive patients treated with guanfacine].
Bazika V; Neuzil P; Tiserová J; Hrabovský F
Cas Lek Cesk; 1986 May; 125(21):637-40. PubMed ID: 3518943
[No Abstract] [Full Text] [Related]
31. [Use of estulic in patients with arterial hypertension].
Kukes VG; Spasskiĭ AV; Alkhazov AI; Rudakov AG; Zisel'man SB
Sov Med; 1985; (12):57-61. PubMed ID: 3913006
[No Abstract] [Full Text] [Related]
32. Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension.
Bune AJ; Chalmers JP; Graham JR; Howe PR; West MJ; Wing LM
Eur J Clin Pharmacol; 1981; 19(5):309-15. PubMed ID: 7016550
[No Abstract] [Full Text] [Related]
33. Comparative study of two antihypertensive agents: guanfacine and guanethidine.
Szám I; Kállay K
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786
[TBL] [Abstract][Full Text] [Related]
34. [A clinical study of guanfacine in the treatment of arterial hypertension].
Kheder A; Souilem J; Hassine L; Ben Maiz H; Ben Moussa F; Ben Ayed H
Tunis Med; 1987 Nov; 65(11):709-12. PubMed ID: 3332951
[No Abstract] [Full Text] [Related]
35. Prolactin, renin, growth hormone, lipoproteins and glucose under guanfacine treatment.
Hauger-Klevene JH; Balossi EC; Scornavacchi JC
Cor Vasa; 1987; 29(4 Suppl 1):17-22. PubMed ID: 3119290
[TBL] [Abstract][Full Text] [Related]
36. Hypotensive effect of guanfacine in essential hypertension: a comparison with clonidine.
Lauro R; Reda G; Spallone L; Anguissola AB
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):81S-82S. PubMed ID: 6994784
[No Abstract] [Full Text] [Related]
37. Comparative studies of guanfacine and methyldopa.
Roeckel A; Heidland A
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):55S-59S. PubMed ID: 6994779
[TBL] [Abstract][Full Text] [Related]
38. Antihypertensive treatment in mild hypertension, its problems and future trends.
Widimský J
Cor Vasa; 1987; 29(4 Suppl 1):1-10. PubMed ID: 3315445
[No Abstract] [Full Text] [Related]
39. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
40. A postmarketing evaluation of guanfacine hydrochloride in mild to moderate hypertension.
Board AW; Perry VP; Shepperson BE; Nyman CE; Carchman SH
Clin Ther; 1988; 10(6):761-75. PubMed ID: 3064907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
